10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,387,235 | -51.4% | 494,236 | -34.1% | 6.48% | -35.4% |
| Q2 2023 | $41,908,032 | +0.1% | 750,502 | 0.0% | 10.04% | +14.0% |
| Q1 2023 | $41,870,507 | +8.2% | 750,502 | -29.3% | 8.80% | -6.7% |
| Q4 2022 | $38,687,692 | +27.9% | 1,061,682 | 0.0% | 9.44% | +82.8% |
| Q3 2022 | $30,237,000 | -37.1% | 1,061,682 | 0.0% | 5.16% | -30.6% |
| Q2 2022 | $48,041,000 | -52.7% | 1,061,682 | -20.5% | 7.43% | -22.5% |
| Q1 2022 | $101,649,000 | -57.6% | 1,336,253 | -17.0% | 9.59% | +24.9% |
| Q4 2021 | $239,948,000 | -8.1% | 1,610,824 | -10.2% | 7.68% | -1.5% |
| Q3 2021 | $261,152,000 | -25.7% | 1,793,871 | 0.0% | 7.80% | +3.9% |
| Q2 2021 | $351,276,000 | -8.6% | 1,793,871 | -15.5% | 7.51% | -20.8% |
| Q1 2021 | $384,327,000 | +5.2% | 2,123,356 | -17.7% | 9.48% | -69.1% |
| Q4 2020 | $365,466,000 | – | 2,580,975 | – | 30.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |